Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review
Metabolic-associated fatty liver disease (MAFLD), previously known as non-alcoholic fatty liver disease, is a significant epidemiological problem and a well-known cardiovascular risk factor. The increasing number of cases creates the need for new therapeutic methods aimed at improving patient outcom...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2023-03-01
|
| Series: | Gastroenterology Review |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Effects-of-PCSK9-inhibitors-on-metabolic-associated-fatty-liver-disease-a-short-review,41,50394,1,1.html |
| _version_ | 1797692363298045952 |
|---|---|
| author | Ewelina Jakielska Paweł Głuszak Marta Walczak Wiesław Bryl |
| author_facet | Ewelina Jakielska Paweł Głuszak Marta Walczak Wiesław Bryl |
| author_sort | Ewelina Jakielska |
| collection | DOAJ |
| description | Metabolic-associated fatty liver disease (MAFLD), previously known as non-alcoholic fatty liver disease, is a significant epidemiological problem and a well-known cardiovascular risk factor. The increasing number of cases creates the need for new therapeutic methods aimed at improving patient outcomes. Recent studies have highlighted the relationship between MAFLD and proprotein convertase subtilisin/kexin type 9 (PCSK9). Based on the available data, PCSK9 inhibitors appear to have beneficial effects in patients with MAFLD, and they may be a treatment option in the future. Further research is necessary to better evaluate the efficiency of PCSK9 inhibitors in MAFLD treatment. |
| first_indexed | 2024-03-12T02:27:32Z |
| format | Article |
| id | doaj.art-f10a8b3be4f34420be2e744f4557997d |
| institution | Directory Open Access Journal |
| issn | 1895-5770 1897-4317 |
| language | English |
| last_indexed | 2024-03-12T02:27:32Z |
| publishDate | 2023-03-01 |
| publisher | Termedia Publishing House |
| record_format | Article |
| series | Gastroenterology Review |
| spelling | doaj.art-f10a8b3be4f34420be2e744f4557997d2023-09-05T11:50:44ZengTermedia Publishing HouseGastroenterology Review1895-57701897-43172023-03-0118214815310.5114/pg.2023.12605450394Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short reviewEwelina JakielskaPaweł GłuszakMarta WalczakWiesław BrylMetabolic-associated fatty liver disease (MAFLD), previously known as non-alcoholic fatty liver disease, is a significant epidemiological problem and a well-known cardiovascular risk factor. The increasing number of cases creates the need for new therapeutic methods aimed at improving patient outcomes. Recent studies have highlighted the relationship between MAFLD and proprotein convertase subtilisin/kexin type 9 (PCSK9). Based on the available data, PCSK9 inhibitors appear to have beneficial effects in patients with MAFLD, and they may be a treatment option in the future. Further research is necessary to better evaluate the efficiency of PCSK9 inhibitors in MAFLD treatment.https://www.termedia.pl/Effects-of-PCSK9-inhibitors-on-metabolic-associated-fatty-liver-disease-a-short-review,41,50394,1,1.htmlnon-alcoholic fatty liver disease fatty liver pcsk9. |
| spellingShingle | Ewelina Jakielska Paweł Głuszak Marta Walczak Wiesław Bryl Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review Gastroenterology Review non-alcoholic fatty liver disease fatty liver pcsk9. |
| title | Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review |
| title_full | Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review |
| title_fullStr | Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review |
| title_full_unstemmed | Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review |
| title_short | Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review |
| title_sort | effects of pcsk9 inhibitors on metabolic associated fatty liver disease a short review |
| topic | non-alcoholic fatty liver disease fatty liver pcsk9. |
| url | https://www.termedia.pl/Effects-of-PCSK9-inhibitors-on-metabolic-associated-fatty-liver-disease-a-short-review,41,50394,1,1.html |
| work_keys_str_mv | AT ewelinajakielska effectsofpcsk9inhibitorsonmetabolicassociatedfattyliverdiseaseashortreview AT pawełgłuszak effectsofpcsk9inhibitorsonmetabolicassociatedfattyliverdiseaseashortreview AT martawalczak effectsofpcsk9inhibitorsonmetabolicassociatedfattyliverdiseaseashortreview AT wiesławbryl effectsofpcsk9inhibitorsonmetabolicassociatedfattyliverdiseaseashortreview |